Market Research Industry Reports

Boryung Pharmaceutical Co Ltd (00850) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Boryung Pharmaceutical Co Ltd. (Boryung) is a pharmaceutical company that develops drugs for the treatment of cancer, infections and gene therapy, besides vaccines, other biopharmaceuticals and new chemical entities (NCE). The companys major products include Kanarb, a new drug for the treatment of hypertension; and Gelfos, an antacid for the treatment of hypergastric acidity, gastritis and gastric fullness. It also offers cardiovascular products, antibiotics, amino acids and cosmetics, and active pharmaceutical ingredients (APIs). Boryung has pipeline products for the treatment of cardiovascular conditions, metabolism, fungal infections, diabetes, dyslipidemia and chronic kidney disease, besides hormones. The company distributes its products through a network of partners across Asia, Europe, the Middle East and Africa. Boryung is headquartered in Seoul, South Korea.

Boryung Pharmaceutical Co Ltd (00850) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Dong Wha Pharma Enters Into Co-Marketing Agreement With Boryung Pharma 10
R-Pharm Enters Into Co-Marketing Agreement With Boryung Pharma For Kanarb 11
Dong Wha Pharma Enters Into Co-Development Agreement With Boryung Pharma For Fimasartan 12
Licensing Agreements 1
Pharma Mar to Enter into Licensing Agreement with Boryung Pharma 1
Ergomed Enters into Licensing Agreement with Boryung Pharma 14
Boryung Pharma Enters into Licensing Agreement with Pharma Mar 15
Harbin Gloria Pharma Enters Into Licensing Agreement With Boryung Pharma 16
Zuellig Pharma Enters into Licensing Agreement with Boryung Pharma for Kanarb 17
Boryung Pharma Enters Into Licensing Agreement With Stendhal For Arakor Plus 18
Acquisition 19
Boryung Pharma to Acquire 2.7% Stake in Cell Therapy Product R&D Company for USD1.Million 19
Boryung Pharmaceutical Co Ltd - Key Competitors 20
Boryung Pharmaceutical Co Ltd - Key Employees 21
Boryung Pharmaceutical Co Ltd - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 2
Methodology 2
About GlobalData 2
Contact Us 2
Disclaimer 2

List Of Tables

List of Tables
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Boryung Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dong Wha Pharma Enters Into Co-Marketing Agreement With Boryung Pharma 10
R-Pharm Enters Into Co-Marketing Agreement With Boryung Pharma For Kanarb 11
Dong Wha Pharma Enters Into Co-Development Agreement With Boryung Pharma For Fimasartan 12
Pharma Mar to Enter into Licensing Agreement with Boryung Pharma 13
Ergomed Enters into Licensing Agreement with Boryung Pharma 14
Boryung Pharma Enters into Licensing Agreement with Pharma Mar 15
Harbin Gloria Pharma Enters Into Licensing Agreement With Boryung Pharma 16
Zuellig Pharma Enters into Licensing Agreement with Boryung Pharma for Kanarb 17
Boryung Pharma Enters Into Licensing Agreement With Stendhal For Arakor Plus 18
Boryung Pharma to Acquire 32.7% Stake in Cell Therapy Product R&D Company for USD1.3 Million 19
Boryung Pharmaceutical Co Ltd, Key Competitors 20
Boryung Pharmaceutical Co Ltd, Key Employees 21
Boryung Pharmaceutical Co Ltd, Other Locations 22

List Of Figures

List of Figures
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Boryung Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Boryung Pharmaceutical Co, Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Boryung Pharmaceutical Co, Ltd Company Profile is a detailed strategic and analytical report on Boryung Pharmaceutical Co, Ltd. The 2018 version of the report offers detailed insights into the companys

USD 200View Report

Boryung Pharmaceutical Co Ltd (00850) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Boryung Pharmaceutical Co Ltd. (Boryung) is a pharmaceutical company that develops drugs for the treatment of cancer, infections and gene therapy, besides vaccines, other biopharmaceuticals and new chemical entities (NCE).

USD 250View Report

La Jolla Pharmaceutical Company (LJPC) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

La Jolla Pharmaceutical Company (La Jolla) is a biopharmaceutical company that discovers, develops and commercializes pharmaceutical products for life threatening diseases. The companys major product includes Giapreza, an injection for

USD 250View Report

Kobayashi Pharmaceutical Co Ltd (4967) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Feb 2018
No. of Pages :23
Country :South Korea
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube